X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (47285) 47285
Book Review (5147) 5147
Publication (2939) 2939
Newsletter (2316) 2316
Conference Proceeding (429) 429
Newspaper Article (178) 178
Book Chapter (175) 175
Dissertation (159) 159
Magazine Article (44) 44
Government Document (31) 31
Trade Publication Article (13) 13
Book / eBook (11) 11
Transcript (10) 10
Web Resource (9) 9
Paper (4) 4
Reference (4) 4
Data Set (2) 2
Journal / eJournal (1) 1
Presentation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (35397) 35397
humans (30509) 30509
paclitaxel (29971) 29971
female (19560) 19560
oncology (17746) 17746
chemotherapy (12863) 12863
paclitaxel - administration & dosage (12144) 12144
cancer (12130) 12130
middle aged (12123) 12123
aged (10650) 10650
male (10241) 10241
antineoplastic combined chemotherapy protocols - therapeutic use (8805) 8805
animals (8732) 8732
adult (8427) 8427
paclitaxel - pharmacology (6964) 6964
treatment outcome (6745) 6745
pharmacology & pharmacy (6063) 6063
cell line, tumor (5232) 5232
cisplatin (5180) 5180
paclitaxel - therapeutic use (5019) 5019
research (4828) 4828
mice (4703) 4703
breast neoplasms - drug therapy (4692) 4692
taxol (4646) 4646
care and treatment (4621) 4621
breast cancer (4408) 4408
carboplatin (4014) 4014
therapy (3926) 3926
apoptosis (3809) 3809
paclitaxel - adverse effects (3720) 3720
docetaxel (3711) 3711
ovarian neoplasms - drug therapy (3685) 3685
carcinoma (3678) 3678
lung neoplasms - drug therapy (3651) 3651
analysis (3566) 3566
ovarian cancer (3493) 3493
antineoplastic combined chemotherapy protocols - adverse effects (3440) 3440
nanoparticles (3369) 3369
trial (3369) 3369
carboplatin - administration & dosage (3263) 3263
neoplasm staging (3186) 3186
drug delivery systems (3057) 3057
tumors (2989) 2989
aged, 80 and over (2987) 2987
drugs (2936) 2936
antineoplastic agents, phytogenic - administration & dosage (2933) 2933
antineoplastic agents - therapeutic use (2925) 2925
doxorubicin (2920) 2920
drug administration schedule (2917) 2917
cisplatin - administration & dosage (2899) 2899
antineoplastic agents (2876) 2876
antineoplastic agents, phytogenic - pharmacology (2861) 2861
breast neoplasms - pathology (2793) 2793
antineoplastic agents - pharmacology (2761) 2761
survival (2760) 2760
carcinoma, non-small-cell lung - drug therapy (2756) 2756
disease-free survival (2751) 2751
dose-response relationship, drug (2647) 2647
antimitotic agents (2637) 2637
drug therapy (2625) 2625
expression (2577) 2577
antineoplastic agents, phytogenic - therapeutic use (2575) 2575
metastasis (2518) 2518
prognosis (2501) 2501
in-vitro (2471) 2471
apoptosis - drug effects (2418) 2418
time factors (2418) 2418
health aspects (2416) 2416
medicine & public health (2308) 2308
breast-cancer (2285) 2285
retrospective studies (2268) 2268
cardiac & cardiovascular systems (2239) 2239
obstetrics & gynecology (2219) 2219
survival rate (2207) 2207
gemcitabine (2206) 2206
biochemistry & molecular biology (2195) 2195
paclitaxel - analogs & derivatives (2188) 2188
taxoids (2122) 2122
antineoplastic agents - administration & dosage (2115) 2115
paclitaxel - chemistry (2101) 2101
combination (2091) 2091
combined modality therapy (2084) 2084
ovarian neoplasms - pathology (2066) 2066
deoxycytidine - analogs & derivatives (2064) 2064
antineoplastic combined chemotherapy protocols - administration & dosage (2043) 2043
cells (2041) 2041
survival analysis (2021) 2021
drug resistance, neoplasm (1997) 1997
lung neoplasms - pathology (1923) 1923
clinical trials (1921) 1921
cell survival - drug effects (1915) 1915
surgery (1901) 1901
article (1894) 1894
cell biology (1889) 1889
follow-up studies (1873) 1873
cancer therapies (1867) 1867
abridged index medicus (1864) 1864
phase-ii (1804) 1804
chemistry, multidisciplinary (1795) 1795
neoplasms - drug therapy (1794) 1794
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (47516) 47516
Japanese (955) 955
Chinese (571) 571
French (374) 374
German (302) 302
Korean (166) 166
Spanish (136) 136
Russian (76) 76
Italian (65) 65
Polish (42) 42
Portuguese (38) 38
Hungarian (27) 27
Czech (21) 21
Turkish (16) 16
Dutch (15) 15
Danish (5) 5
Hebrew (5) 5
Swedish (5) 5
Croatian (4) 4
Lithuanian (4) 4
Finnish (3) 3
Slovak (3) 3
Slovenian (2) 2
Bulgarian (1) 1
Norwegian (1) 1
Persian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biomaterials, ISSN 0142-9612, 09/2017, Volume 140, pp. 162 - 169
In the latest trend of anticancer chemotherapy research, there were many macromolecular anticancer drugs developed based on enhanced permeability and retention... 
Liposome | Micelle | Human serum albumin | Nitric oxide | Enhanced permeability and retention effect | Nanoparticle albumin bound paclitaxel | MATERIALS SCIENCE, BIOMATERIALS | NAB-PACLITAXEL | ENGINEERING, BIOMEDICAL | DOXORUBICIN | TUMOR | VASCULAR-PERMEABILITY | ANTITUMOR DRUGS | DELIVERY | THERAPEUTIC-EFFICACY | IN-VIVO | NITRIC-OXIDE | ACCUMULATION | Neoplasms - metabolism | Paclitaxel - pharmacology | Pancreatic Neoplasms - metabolism | Humans | Melanoma, Experimental - drug therapy | Protein Multimerization | Capillary Permeability - drug effects | Male | Melanoma, Experimental - metabolism | Antineoplastic Agents - therapeutic use | Paclitaxel - pharmacokinetics | Pancreatic Neoplasms - drug therapy | Albumins - therapeutic use | Nitroso Compounds - pharmacology | Albumin-Bound Paclitaxel - pharmacokinetics | Albumin-Bound Paclitaxel - therapeutic use | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Nitroso Compounds - therapeutic use | Mice, Inbred C57BL | Pancreatic Neoplasms - pathology | Albumin-Bound Paclitaxel - pharmacology | Melanoma, Experimental - pathology | Serum Albumin, Human - pharmacokinetics | Paclitaxel - therapeutic use | Neoplasms - drug therapy | Drug Synergism | Serum Albumin, Human - therapeutic use | Albumins - pharmacokinetics | Albumins - pharmacology | Animals | Serum Albumin, Human - pharmacology | Cell Line, Tumor | Mice | Mice, Inbred BALB C | Nitroso Compounds - pharmacokinetics | Neoplasms - pathology | Nitric Oxide - metabolism | Drugs | Drug delivery systems | Melanoma | Albumin | Permeability | Antineoplastic agents | Vehicles | Antimitotic agents | Chemotherapy | Colon cancer | Analysis | Pancreatic cancer | Cancer | Index Medicus
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 02/2013, Volume 166, Issue 1, pp. 66 - 74
The performance and safety of current antineoplastic agents, particularly water-insoluble drugs, are still far from satisfactory. For example, the currently... 
N-(2-hydroxypropyl)methacrylamide (HPMA) | Biodegradable multiblock copolymer | Paclitaxel | Ovarian cancer | MOLECULAR-WEIGHT | N-(2-hydroxypropyl)methactylamide (HPMA) | CANCER | CHEMISTRY, MULTIDISCIPLINARY | OVARIAN-CARCINOMA | CHEMOTHERAPY | TARGETING DELIVERY | N-(2-HYDROXYPROPYL)METHACRYLAMIDE COPOLYMERS | BODY DISTRIBUTION | CONJUGATE | PHARMACOLOGY & PHARMACY | IN-VIVO EVALUATION | CREMOPHOR EL | Molecular Weight | Nanoparticles - chemistry | Paclitaxel - chemical synthesis | Biocompatible Materials - chemistry | Humans | Ovarian Neoplasms - pathology | Acrylic Resins - chemical synthesis | Paclitaxel - pharmacokinetics | Drug Carriers - chemistry | Biocompatible Materials - chemical synthesis | Tissue Distribution | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Acrylic Resins - pharmacokinetics | Female | Antineoplastic Agents, Phytogenic - therapeutic use | Paclitaxel - administration & dosage | Antineoplastic Agents, Phytogenic - pharmacokinetics | Ovarian Neoplasms - drug therapy | Cell Survival - drug effects | Paclitaxel - analogs & derivatives | Drug Carriers - chemical synthesis | Acrylic Resins - chemistry | Paclitaxel - therapeutic use | Acrylamides - chemistry | Xenograft Model Antitumor Assays | Acrylic Resins - therapeutic use | Animals | Mice, Nude | Cell Line, Tumor | Mice | Acrylamides - chemical synthesis | Drugs | Drug delivery systems | Dosage and administration | Vehicles | Index Medicus | Ascites | paclitaxel | biodegradable multiblock copolymer | ovarian cancer
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 3/2008, Volume 108, Issue 2, pp. 241 - 250
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2000, Volume 18, Issue 12, pp. 2354 - 2362
Purpose: To confirm the promising phase II results of docetaxel monotherapy, this phase III trial was conducted of chemotherapy for patients with advanced... 
ONCOLOGY | PACLITAXEL
Journal Article
by Meng, H and Wang, MY and Liu, HY and Liu, XS and Situ, A and Wu, B and Ji, ZX and Chang, CH and Nel, AE
ACS NANO, ISSN 1936-0851, 04/2015, Volume 9, Issue 4, pp. 3540 - 3557
Recently, a commercial albumin-bound paclitaxel (PTX) nanocarrier (Abraxane) was approved as the first new drug for pancreatic ductal adenocarcinoma in almost... 
SUPPORTED MEMBRANES | paclitaxel | PHYSICAL-PROPERTIES | synergy | mesoporous silica nanoparticle | VIVO | NAB-PACLITAXEL | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | MODEL | CYTIDINE DEAMINASE | CHEMISTRY, MULTIDISCIPLINARY | OVERCOME DRUG-RESISTANCE | co-delivery | pancreatic cancer | IN-VITRO | ratiometric | gemcitabine | BILAYERS PROTOCELLS | NANOTECHNOLOGY | Albumins - chemistry | Deoxycytidine - chemistry | Paclitaxel - pharmacology | Pancreatic Neoplasms - metabolism | Nanoparticles - chemistry | Humans | Deoxycytidine - pharmacology | Antineoplastic Agents - therapeutic use | Drug Carriers - chemistry | Pancreatic Neoplasms - drug therapy | Albumins - therapeutic use | Paclitaxel - chemistry | Deoxycytidine - therapeutic use | Female | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Pancreatic Neoplasms - pathology | Silicon Dioxide - chemistry | Antineoplastic Agents - chemistry | Paclitaxel - therapeutic use | Drug Synergism | Albumins - pharmacology | Animals | Cell Transformation, Neoplastic | Cytidine Deaminase - metabolism | Cell Line, Tumor | Mice | Lipid Bilayers - chemistry | Porosity | Deoxycytidine - analogs & derivatives | Index Medicus | Drugs | Effectiveness | Metabolites | Biocompatibility | Lipids | Nanostructure | Tumors | Cancer
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 3/2015, Volume 32, Issue 3, pp. 1002 - 1016
Albumin nanoparticles have been explored as a promising delivery system for various therapeutic agents. One limitation of such formulations is their poor... 
Biochemistry, general | Biomedical Engineering | colloidal stability | paclitaxel | Biomedicine | Pharmacy | Medical Law | Pharmacology/Toxicology | pharmacokinetic | liposome | albumin nanoparticle | VITRO | COMPLEX MICELLES | DRUG-DELIVERY | HUMAN SERUM-ALBUMIN | CHEMISTRY, MULTIDISCIPLINARY | POLYMERIC NANOPARTICLES | FORMULATIONS | BOUND PACLITAXEL | PHARMACOLOGY & PHARMACY | POLYETHYLENE-GLYCOL | IN-VIVO EVALUATION | BLOCK-COPOLYMER | Albumins - chemistry | Injections, Intravenous | Paclitaxel - pharmacology | Albumin-Bound Paclitaxel | Humans | Half-Life | Male | Melanoma, Experimental - metabolism | Polyethylene Glycols - chemistry | Paclitaxel - pharmacokinetics | Breast Neoplasms - metabolism | Nanoparticles | Tissue Distribution | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Lipids - chemistry | G2 Phase Cell Cycle Checkpoints - drug effects | MCF-7 Cells | Female | Paclitaxel - administration & dosage | Antineoplastic Agents, Phytogenic - pharmacokinetics | Nanomedicine | Cell Survival - drug effects | Drug Stability | Solubility | Melanoma, Experimental - pathology | Antineoplastic Agents, Phytogenic - chemistry | Technology, Pharmaceutical - methods | Chemistry, Pharmaceutical | Particle Size | Animals | Breast Neoplasms - pathology | Mice | Mice, Inbred BALB C | Liposomes | Antineoplastic Agents, Phytogenic - pharmacology | Thin films | Chemotherapy | Analysis | Paclitaxel | Albumin | Drugstores | Dielectric films | Chromatography | Cancer | Proteins | Drug delivery systems | Pharmaceutical sciences | Tumors | Index Medicus
Journal Article
Biomaterials, ISSN 0142-9612, 2011, Volume 32, Issue 31, pp. 8010 - 8020
Abstract Targeted delivery of therapeutic nanoparticles in a disease-specific manner represents a potentially powerful technology especially when treating... 
Advanced Basic Science | Dentistry | Chemotherapy | Aptamer | Drug delivery | Nanoparticle | Nucleolin | Paclitaxel | PRIMARY BRAIN-TUMORS | VITRO | MATERIALS SCIENCE, BIOMATERIALS | GLIOBLASTOMA-MULTIFORME | ENGINEERING, BIOMEDICAL | GLIOMA GROWTH | CELL-SURFACE | BIODISTRIBUTION | ANTITUMOR-ACTIVITY | IN-VIVO EVALUATION | Injections, Intravenous | Paclitaxel - pharmacology | Nanoparticles - chemistry | Humans | Oligodeoxyribonucleotides - chemical synthesis | Oligodeoxyribonucleotides - chemistry | Polyethylene Glycols - chemistry | Paclitaxel - pharmacokinetics | Aptamers, Nucleotide - chemical synthesis | Drug Delivery Systems | Glioma - pathology | Surface Properties - drug effects | Inhibitory Concentration 50 | Paclitaxel - administration & dosage | Aptamers, Nucleotide - pharmacology | Photoelectron Spectroscopy | Tissue Distribution - drug effects | Lactic Acid - chemistry | Magnetic Resonance Spectroscopy | Electrophoresis, Polyacrylamide Gel | Kaplan-Meier Estimate | Aptamers, Nucleotide - chemistry | Rats | Treatment Outcome | Static Electricity | Paclitaxel - therapeutic use | Particle Size | Animals | Mice, Nude | Polyglycolic Acid - chemistry | Cell Proliferation - drug effects | Mice | Oligodeoxyribonucleotides - pharmacology | Glioma - drug therapy | Drugs | Nanoparticles | Urea | Drug delivery systems | Biological products | Gliomas | Brain tumors | Vehicles | Index Medicus
Journal Article
Journal Article
Journal Article